Administration of Protein‐Conjugate Pneumococcal Vaccine to Patients Who Have Invasive Disease after Splenectomy Despite Their Having Received 23‐Valent Pneumococcal Polysaccharide Vaccine
Daniel M. Musher(Michael E. DeBakey VA Medical Center), A. Clinton White(The University of Texas Medical Branch at Galveston), Sandra Romero‐Steiner(Centers for Disease Control and Prevention), Heather Ceasar, Benjamin Musher(Baylor College of Medicine), Erna M. Kojic, Joseph Gathe
Cited by 35
Related Papers
Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants
|Blood|2003|442
Preoperative Treatment of Locally Advanced Rectal Cancer
|New England Journal of Medicine|2023|440
<i>Aspergillus</i>Galactomannan Enzyme Immunoassay and Quantitative PCR for Diagnosis of Invasive Aspergillosis with Bronchoalveolar Lavage Fluid
|Journal of Clinical Microbiology|2004|282
Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study)
|Clinical Cancer Research|2019|260
Contagious Acute Gastrointestinal Infections
|New England Journal of Medicine|2004|175